Cargando…
Network Pharmacology Integrated Molecular Docking Reveals the Mechanism of Anisodamine Hydrobromide Injection against Novel Coronavirus Pneumonia
BACKGROUND: The Coronavirus Disease 2019 (COVID-19) outbreak in Wuhan, China, was caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Anisodamine hydrobromide injection (AHI), the main ingredient of which is anisodamine, is a listed drug for improving microcirculation in China. A...
Autores principales: | Su, Jinsong, Liu, Zixuan, Liu, Chuan, Li, Xuanhao, Wang, Yi, Zhao, Jing, Wu, Qingjiang, Zheng, Shichao, Zhang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411467/ https://www.ncbi.nlm.nih.gov/pubmed/32802131 http://dx.doi.org/10.1155/2020/5818107 |
Ejemplares similares
-
Anisodamine hydrobromide ameliorates cardiac damage after resuscitation
por: Dong, Gui-Juan, et al.
Publicado: (2022) -
Protective effect of anisodamine hydrobromide on lipopolysaccharide-induced acute kidney injury
por: Wan, Feng, et al.
Publicado: (2020) -
Anisodamine hydrobromide in the treatment of critically ill patients with septic shock: a multicenter randomized controlled trial
por: Zhang, Fang, et al.
Publicado: (2023) -
Anti-Apoptotic Role of Sanhuang Xiexin Decoction and Anisodamine in Endotoxemia
por: Liu, Zixuan, et al.
Publicado: (2021) -
Darifenacin hydrobromide
por: Selvanayagam, S., et al.
Publicado: (2009)